https://crstodayeurope.com/news/eyenovia-announces-fda-acceptance-of-ind-application-for-micropine/2476316/daily0.7https://crstodayeurope.com/news/avedro-launches-initial-public-offering/2476317/daily0.7https://crstodayeurope.com/news/graybug-vision-appoints-frederic-guerard-as-chief-executive-officer/2476318/daily0.7https://crstodayeurope.com/news/eye-movements-may-flag-cognitive-impairment-in-schizophrenia/2476319/daily0.7https://crstodayeurope.com/news/galimedix-therapeutics-presents-data-for-investigational-eyedrops-containing-gal-101/2476320/daily0.7https://crstodayeurope.com/news/silgan-to-debut-iridya-preservative-free-multi-dose-eye-dropper/2476322/daily0.7https://crstodayeurope.com/news/harrow-health-announces-11-million-series-a-financing-for-melt-pharmaceuticals-subsidiary/2476323/daily0.7https://crstodayeurope.com/news/first-implantation-of-rayone-aspheric-fully-preloaded-iol-in-us-completed-by-william-f-wiley-md/2476324/daily0.7https://crstodayeurope.com/news/corneagen-to-acquire-keralink-domestic-eye-bank-operations/2476326/daily0.7https://crstodayeurope.com/news/zeiss-develops-multifunctional-smart-glass/2476327/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-announces-us-commercial-launch-of-yutiq/2476328/daily0.7https://crstodayeurope.com/news/seco-international-names-j-max-ernst-od-as-2020-president/2476329/daily0.7https://crstodayeurope.com/news/new-us-experiments-aim-to-create-gene-edited-human-embryos/2476330/daily0.7https://crstodayeurope.com/news/spectralis-high-magnification-module-receives-ce-marking/2476331/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-announces-availability-in-europe-of-tecnis-eyhance-iol/2476332/daily0.7https://crstodayeurope.com/news/clinical-trials-planned-for-iris-recognition-based-patient-identification-software/2476333/daily0.7https://crstodayeurope.com/news/uspstf-reaffirms-advice-on-prevention-of-gonococcal-eye-infections-in-newborns/2476334/daily0.7https://crstodayeurope.com/news/zeimer-manufactured-its-1000th-laser-at-its-berne-production-facility/2476335/daily0.7https://crstodayeurope.com/news/university-of-alberta-scientists-pinpoint-a-cause-of-pigmentary-glaucoma/2476337/daily0.7https://crstodayeurope.com/news/investigators-seek-optimized-ophthalmology-clinical-trial-outcomes/2476338/daily0.7https://crstodayeurope.com/news/janssen-enters-license-agreement-with-meiragtx-to-develop-gene-therapy-programs-for-inherited-retinal-diseases/2476340/daily0.7https://crstodayeurope.com/news/bausch-health-reduces-debt-by-additional-100-million/2476341/daily0.7https://crstodayeurope.com/news/founders-of-the-lens-butler-announce-boxsee-a-new-contact-lens-subscription-service/2476342/daily0.7https://crstodayeurope.com/news/study-scleral-lenses-coated-with-tangible-hydra-peg-improve-dry-eye-symptoms-comfort/2476344/daily0.7https://crstodayeurope.com/news/controlled-trial-shows-promise-of-donated-stem-cells-in-restoring-vision/2476345/daily0.7https://crstodayeurope.com/news/multicolor-holography-technology-could-enable-extremely-compact-3d-displays/2479595/daily0.7https://crstodayeurope.com/news/nicox-announces-fda-acceptance-of-investigational-nda-for-ncx-4251-phase-2-trial-in-blepharitis/2479597/daily0.7https://crstodayeurope.com/news/statement-from-fda-leadership-on-a-record-year-for-device-innovation/2479598/daily0.7https://crstodayeurope.com/news/ocutech-starts-national-roll-out-of-new-ves-falcon-autofocus-bioptic-telescope/2479599/daily0.7https://crstodayeurope.com/news/tangible-science-introduces-lens-care-system-for-custom-contact-lenses-coated-with-tangible-hydra-peg/2479600/daily0.7https://crstodayeurope.com/news/nicox-establishes-high-profile-glaucoma-clinical-advisory-board/2479601/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-appoints-david-guyer-md-to-board-of-directors/2479602/daily0.7https://crstodayeurope.com/news/cvp-partners-with-virginia-eye-consultants-to-create-multiregional-platform/2483627/daily0.7https://crstodayeurope.com/news/haag-streit-academy-to-offer-free-copy-of-visual-field-digest-at-gold-standard-perimetry-course/2483628/daily0.7https://crstodayeurope.com/news/fda-commissioner-gottlieb-announces-efforts-to-improve-assessment-of-rems-programs/2479604/daily0.7https://crstodayeurope.com/news/ohr-pharmaceutical-announces-reverse-stock-split-to-be-effective-february-4-2019/2483629/daily0.7https://crstodayeurope.com/news/american-foundation-for-the-blind-to-present-its-highest-honors-at-annual-conference/2483630/daily0.7https://crstodayeurope.com/news/leading-vision-and-eye-health-groups-join-together-to-urge-us-surgeon-general-to-issue-call-to-action-for-year-2020/2483605/daily0.7https://crstodayeurope.com/news/bausch-lomb-introduces-zen-multifocal-scleral-lens-for-presbyopia/2476173/daily0.7https://crstodayeurope.com/news/lifestyle-choices-may-help-glaucoma-patients-preserve-eyesight/2476174/daily0.7https://crstodayeurope.com/news/johnson-johnson-reports-2018-fourth-quarter-results/2476175/daily0.7https://crstodayeurope.com/news/us-outpatient-surgical-procedures-market-to-reach-144-million-procedures-by-2023/2483606/daily0.7https://crstodayeurope.com/news/cultivating-4-d-tissues-the-self-curving-cornea/2476176/daily0.7https://crstodayeurope.com/news/compulink-showcases-smart-ophthalmology-ehr-solution-at-hawaiian-eye-2019/2476177/daily0.7https://crstodayeurope.com/news/dorc-unveils-enhancements-to-the-eva-phacovitrectomy-system/2476178/daily0.7https://crstodayeurope.com/news/burnout-rises-above-50-in-some-specialties-new-survey-shows/2476179/daily0.7https://crstodayeurope.com/news/allergan-mohawk-tribe-ask-for-supreme-court-review-of-scrutinized-patent-case/2476180/daily0.7https://crstodayeurope.com/news/cyclosporine-emulsion-promising-in-vernal-keratoconjunctivitis/2476182/daily0.7https://crstodayeurope.com/news/manf-therapeutics-receives-notice-of-allowance-from-us-patent-trademark-office-covering-the-use-of-manf-or-cdnf-for-ophthalmic-diseases/2476184/daily0.7https://crstodayeurope.com/news/fda-to-boost-staff-to-help-handle-anticipated-increase-in-cell-and-gene-therapy-filings/2476185/daily0.7https://crstodayeurope.com/news/new-national-survey-reveals-greater-risk-of-seniors-switching-medicare-advantage-plans-in-2019/2476186/daily0.7https://crstodayeurope.com/news/acuity-pro-launches-acuity-ten-digital-software-and-system/2476187/daily0.7https://crstodayeurope.com/news/richard-litwin-md-honored-with-ascrs-foundations-2019-chang-humanitarian-award/2476188/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-launches-the-uks-first-free-nationwide-recycling-program-for-all-contact-lenses/2476189/daily0.7https://crstodayeurope.com/news/survey-80-of-consumers-would-be-more-likely-to-visit-a-doctor-if-they-could-see-the-exact-out-of-pocket-cost-on-their-smartphone/2476190/daily0.7https://crstodayeurope.com/news/us-house-oversight-committee-launches-investigation-into-prescription-drug-pricing/2476191/daily0.7https://crstodayeurope.com/news/glaucoma-drug-reduces-iop-spike-after-anti-vegf-injections/2476192/daily0.7https://crstodayeurope.com/news/take-diabetes-into-consideration-when-assessing-for-glaucoma/2476193/daily0.7https://crstodayeurope.com/news/analysts-believe-ma-activity-in-the-pharmaceutical-sector-could-rise-in-2019/2476194/daily0.7https://crstodayeurope.com/news/common-glaucoma-visual-test-lacks-consideration-for-central-vision-loss/2476195/daily0.7https://crstodayeurope.com/news/atlantic-street-capital-forms-advancing-eyecare-holdings-with-partnership-of-lombart-instrument-and-marco-ophthalmic/2476196/daily0.7https://crstodayeurope.com/news/us-democratic-lawmakers-introduce-bills-targeting-drug-pricing/2476197/daily0.7https://crstodayeurope.com/news/ocular-therapeutix-submits-supplemental-nda-for-dextenza-for-the-treatment-of-postoperative-inflammation/2476198/daily0.7https://crstodayeurope.com/news/in-memoriam-jack-j-kanski-frcs-frcophth/2476199/daily0.7https://crstodayeurope.com/news/wize-pharma-announces-publication-of-loa2-data-on-treatment-of-moderately-severe-sjogrens-syndrome-related-dry-eye/2476200/daily0.7https://crstodayeurope.com/news/tiny-digital-tags-improve-eye-care-by-tracking-every-step/2476201/daily0.7https://crstodayeurope.com/news/cvp-partners-with-northwest-and-central-ohio-ophthalmology-practice/2476202/daily0.7https://crstodayeurope.com/news/ema-handed-down-fewer-positive-drug-opinions-in-2018/2476203/daily0.7https://crstodayeurope.com/news/fda-approved-record-number-of-drugs-in-2018/2476204/daily0.7https://crstodayeurope.com/news/takeda-ceo-optimistic-about-growth-prospects-as-drugmaker-finalizes-shire-takeover/2476205/daily0.7https://crstodayeurope.com/news/coopervision-acquires-blanchard-contact-lenses-expanding-presence-in-specialty-segment/2476206/daily0.7https://crstodayeurope.com/news/global-demand-for-refractive-surgery-growing-after-economic-rebound-in-major-markets/2476207/daily0.7https://crstodayeurope.com/news/riata-capitals-acuity-eyecare-group-completes-acquisitions-in-colorado-and-nebraska/2476208/daily0.7https://crstodayeurope.com/news/eyeque-announces-availability-of-pdcheck-on-kickstarter-website/2476210/daily0.7https://crstodayeurope.com/news/leica-biosystems-receives-us-patent-for-rtf-extreme-speed-scanning-technology/2476211/daily0.7https://crstodayeurope.com/news/righteye-surpasses-100000-patient-tests/2476212/daily0.7https://crstodayeurope.com/news/healthe-named-one-of-the-nations-20-hottest-health-start-ups/2476213/daily0.7https://crstodayeurope.com/news/proqr-reaches-agreement-with-the-fda-on-design-of-phase-2-3-pivotal-trial-for-sepofarsen-qr-110-for-lebers-congenital-amaurosis-10/2476214/daily0.7https://crstodayeurope.com/news/allergan-announces-positive-3-month-topline-results-from-second-phase-3-study-of-bimatoprost-sr-implant-for-lowering-iop/2476215/daily0.7https://crstodayeurope.com/news/staar-surgical-expects-fourth-quarter-icl-sales-to-rise-42-china-units-nearly-double-u-s-market-returns-to-growth/2476216/daily0.7https://crstodayeurope.com/news/kala-pharmaceuticals-announces-the-launch-of-inveltys-and-the-hiring-of-a-specialty-ophthalmology-sales-organization/2476217/daily0.7https://crstodayeurope.com/news/oculogica-receives-fda-marketing-approval-for-eyebox-the-first-noninvasive-baseline-free-test-for-concussion/2476218/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-announces-positive-topline-results-of-netarsudil-ophthalmic-solution-in-pilot-phase-2-study/2476219/daily0.7https://crstodayeurope.com/news/oculis-in-licenses-phase-2-topical-anti-tnf-alpha-antibody-from-novartis/2476220/daily0.7https://crstodayeurope.com/news/oculis-raises-15-7-million-to-advance-development-of-novel-topical-treatments-for-ophthalmic-diseases/2476221/daily0.7https://crstodayeurope.com/news/bausch-lomb-announces-health-canada-approval-of-vyzulta-for-the-treatment-of-glaucoma/2476223/daily0.7https://crstodayeurope.com/news/dompe-announces-first-treatment-with-oxervate-eye-drops-for-neurotrophic-keratitis-nk/2476224/daily0.7https://crstodayeurope.com/news/american-vision-partners-announces-partnership-with-las-vegas-abrams-eye-institute/2476225/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-to-launch-dexycu-and-yutiq-in-first-quarter-of-2019/2476226/daily0.7https://crstodayeurope.com/news/focus-vision-supplements-launches-reformulated-version-of-omega-3-focus-relief-plus/2476228/daily0.7https://crstodayeurope.com/news/george-a-williams-md-begins-term-as-2019-president-of-the-american-academy-of-ophthalmology/2476229/daily0.7https://crstodayeurope.com/news/results-rna-issues-voluntary-worldwide-recall-of-lubrisine-eye-drops-due-to-manufacturing-sterility-concerns-and-undeclared-colloidal-silver/2476230/daily0.7https://crstodayeurope.com/news/ophthotech-announces-the-addition-of-ophthalmic-industry-leader-calvin-w-roberts-md-to-its-board-of-directors/2476231/daily0.7https://crstodayeurope.com/news/diet-soda-linked-to-increased-risk-for-diabetic-retinopathy/2476232/daily0.7https://crstodayeurope.com/news/imprimis-pharmaceuticals-changes-name-to-harrow-health/2476233/daily0.7https://crstodayeurope.com/news/lightmed-founder-and-executive-chairman-gary-lee-reassumes-ceo-role/2476234/daily0.7https://crstodayeurope.com/news/unum-poll-finds-40-percent-of-adults-spend-12-hours-on-devices-each-day/2476235/daily0.7https://crstodayeurope.com/news/ocular-therapeutix-announces-completion-of-debt-refinancing/2476236/daily0.7https://crstodayeurope.com/news/american-academy-of-ophthalmology-calls-on-states-to-maintain-high-safety-standards-for-surgical-eye-care/2476237/daily0.7https://crstodayeurope.com/news/2018-best-of-eyetube/2476238/daily0.7https://crstodayeurope.com/news/amd-monitoring-comes-home-the-promise-of-innovative-remote-tech/2476239/daily0.7https://crstodayeurope.com/news/kala-pharmaceuticals-announces-nda-for-kpi-121-0-25-for-dry-eye-disease-has-been-accepted-for-review-by-fda/2476240/daily0.7https://crstodayeurope.com/news/nicox-enters-into-collaboration-with-novaliq-on-topical-ophthalmic-formulations/2476241/daily0.7https://crstodayeurope.com/news/carl-zeiss-meditec-completes-acquisition-of-iantech/2476242/daily0.7https://crstodayeurope.com/news/istar-medicals-miniject-maintains-exceptional-results-in-first-in-human-trial-one-year-post-surgery-star-i/2476244/daily0.7https://crstodayeurope.com/news/tpg-capital-backs-bvi-to-acquire-physiol-group-sa/2476246/daily0.7https://crstodayeurope.com/news/clearside-biomedical-submits-nda-for-xipere-for-the-treatment-of-macular-edema-associated-with-uveitis/2476247/daily0.7https://crstodayeurope.com/news/alcon-announces-acquisition-of-tear-film-innovations/2476248/daily0.7https://crstodayeurope.com/news/chugais-satralizumab-receives-fda-breakthrough-therapy-designation-for-neuromyelitis-optica-and-neuromyelitis-optica-spectrum-disorders/2476249/daily0.7https://crstodayeurope.com/news/for-2019-ada-and-acc-align-their-diabetes-recommendations/2476250/daily0.7https://crstodayeurope.com/news/market-scope-global-dry-eye-products-market-to-total-6-2-billion-in-2023/2476251/daily0.7https://crstodayeurope.com/news/first-ic-8-small-aperture-iol-implanted-in-the-united-states/2476252/daily0.7https://crstodayeurope.com/news/study-suggests-cbd-may-worsen-glaucoma-raise-eye-pressure/2476253/daily0.7https://crstodayeurope.com/news/optometric-organizations-reach-agreement-on-establishing-new-cope-governing-committee/2476254/daily0.7https://crstodayeurope.com/news/notal-vision-engages-wasatch-photonics-bringing-ai-enabled-home-based-oct-closer-to-market/2479605/daily0.7https://crstodayeurope.com/news/oculus-presents-the-new-imagecam-3/2479606/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-added-to-nasdaq/2479607/daily0.7https://crstodayeurope.com/news/proqr-announces-publication-of-qr-110-data-for-lebers-congenital-amaurosis-10/2479608/daily0.7https://crstodayeurope.com/news/mount-sinai-recruits-internationally-recognized-ophthalmologists-to-expand-leadership/2479609/daily0.7https://crstodayeurope.com/news/nicox-and-ocumension-therapeutics-sign-exclusive-license-agreement-to-develop-and-commercialize-ncx-470-in-the-chinese-market/2479610/daily0.7https://crstodayeurope.com/news/fda-clears-first-daily-disposable-silicone-hydrogel-contact-lens-coated-with-modified-formula-of-tangible-hydra-peg/2479611/daily0.7https://crstodayeurope.com/news/higher-eye-pressure-after-anti-vegf-therapy-needs-more-attention/2476255/daily0.7https://crstodayeurope.com/news/od-os-releases-intuitive-iridotomy-treatment-with-the-navilas-577s-retina-laser/2479613/daily0.7https://crstodayeurope.com/news/bausch-health-to-purchase-majority-of-synergy-pharmaceuticals-assets-including-trulance/2479614/daily0.7https://crstodayeurope.com/news/university-of-dayton-researcher-named-on-second-patent-for-device-to-provide-better-relief-for-glaucoma-patients/2479616/daily0.7https://crstodayeurope.com/news/the-number-of-optometric-practices-offering-neurolens-contoured-prism-lenses-more-than-quadrupled-in-2018/2479617/daily0.7https://crstodayeurope.com/news/rayone-aspheric-fully-preloaded-iol-receives-fda-clearance/2479618/daily0.7https://crstodayeurope.com/news/gensight-biologics-reports-sustained-quality-of-life-improvements-at-week-72-of-phase-3-reverse-clinical-trial/2479619/daily0.7https://crstodayeurope.com/news/study-glaukos-istent-inject-implantation-with-concomitant-cataract-surgery-provides-sustained-reduction-in-iop-and-medication-burden/2479620/daily0.7https://crstodayeurope.com/news/seco-international-partners-with-the-american-society-of-optometric-surgeons-for-seco-2019/2479621/daily0.7https://crstodayeurope.com/news/opternative-changes-names-to-visibly-to-better-reflect-eye-care-industry-partnerships/2479622/daily0.7https://crstodayeurope.com/news/wills-eye-hospitals-training-in-ophthalmology-voted-1-top-eye-residency-program-in-nation/2479623/daily0.7https://crstodayeurope.com/news/anthem-blue-cross-blue-shield-now-covering-avedros-corneal-cross-linking-procedure/2479624/daily0.7https://crstodayeurope.com/news/ophthalmic-investment-funds-led-by-retinal-gene-therapy-developers/2476147/daily0.7https://crstodayeurope.com/news/santen-announces-scottish-medicines-consortium-approval-of-verkazia-for-severe-vernal-keratoconjunctivitis/2476148/daily0.7https://crstodayeurope.com/news/alcon-introduces-new-medical-affairs-website-in-north-america-expanding-support-for-patient-care-and-clinical-community/2476149/daily0.7https://crstodayeurope.com/news/akorn-ceo-steps-down-after-loss-of-4-3-billion-fresenius-deal/2476150/daily0.7https://crstodayeurope.com/news/criminal-case-against-james-mazzo-dismissed/2476151/daily0.7https://crstodayeurope.com/news/federal-trade-commission-penalizes-online-sellers-for-violating-contact-lens-rule-bans-them-from-selling-lenses-in-future/2476152/daily0.7https://crstodayeurope.com/news/center-for-vision-and-population-health-at-prevent-blindness-established-to-implement-strategies-to-address-eye-health/2476154/daily0.7https://crstodayeurope.com/news/bausch-lomb-receives-fda-clearance-for-ultra-multifocal-for-astigmatism-contact-lenses/2476156/daily0.7https://crstodayeurope.com/news/study-dietary-supplements-dont-prevent-chronic-disease/2476158/daily0.7https://crstodayeurope.com/news/spark-therapeutics-gene-therapy-pioneers-win-1-million-sanford-lorraine-cross-award/2476159/daily0.7https://crstodayeurope.com/news/atpo-announces-jessica-barr-as-new-president/2476160/daily0.7https://crstodayeurope.com/news/coburn-technologies-introduces-new-portable-slit-lamp-to-product-line/2479625/daily0.7https://crstodayeurope.com/news/study-ocular-technology-provides-early-detection-of-alzheimers-disease/2479626/daily0.7https://crstodayeurope.com/news/takeda-shareholders-back-shire-purchase/2479627/daily0.7https://crstodayeurope.com/news/nidek-launches-feedback-exam-for-low-vision-care-and-scotopic-microperimetry/2479628/daily0.7https://crstodayeurope.com/news/mdi-biological-laboratory-scientist-receives-scientific-innovation-award-for-research-on-amd/2476162/daily0.7https://crstodayeurope.com/news/editas-medicine-announces-fda-acceptance-of-ind-application-for-lca10-treatment-edit-101/2476163/daily0.7https://crstodayeurope.com/news/alcons-phaco-development-pd-program-celebrates-10-years/2476164/daily0.7https://crstodayeurope.com/news/proqr-announces-clearance-of-ind-to-start-clinical-trial-of-qr-421a-in-usher-syndrome-type-2-patients/2476165/daily0.7https://crstodayeurope.com/news/bausch-lomb-announces-exclusive-agreement-with-modulight-to-develop-new-photodynamic-laser/2476166/daily0.7https://crstodayeurope.com/news/eyenovia-completes-patient-enrollment-in-microstat-mist-1-study-and-enrolls-first-patient-in-mist-2-study/2476167/daily0.7https://crstodayeurope.com/news/market-scope-launches-new-website-and-entry-into-orthopedics/2476168/daily0.7https://crstodayeurope.com/news/sangamo-announces-completion-of-txcell-acquisition/2476169/daily0.7https://crstodayeurope.com/news/first-patient-successfully-implanted-with-implandatas-eye-pressure-sensor-for-continual-glaucoma-monitoring/2476170/daily0.7https://crstodayeurope.com/news/ocular-therapeutix-announces-fda-approval-of-dextenza-for-the-treatment-of-ocular-pain-following-ophthalmic-surgery/2476171/daily0.7https://crstodayeurope.com/news/eye-testing-may-aid-early-diagnosis-of-creutzfeldt-jakob-disease/2479629/daily0.7https://crstodayeurope.com/news/bayer-to-cut-12000-jobs-exit-vet-unit-amid-drag-from-suits/2479631/daily0.7https://crstodayeurope.com/news/eyecare-partners-acquires-holcomb-laser-center/2479632/daily0.7https://crstodayeurope.com/news/alcon-outlines-growth-strategy-as-spinoff-nears/2479633/daily0.7https://crstodayeurope.com/news/envision-conference-to-split-in-two-in-2019/2479634/daily0.7https://crstodayeurope.com/news/reading-speed-motor-skills-affect-self-perception-in-kids-with-amblyopia/2479635/daily0.7https://crstodayeurope.com/news/dry-eye-symptom-screens-show-modest-accuracy/2479636/daily0.7https://crstodayeurope.com/news/eyenovia-publishes-pg21-phase-2-trial-results-examining-iop-lowering-effect-and-patient-usability/2479637/daily0.7https://crstodayeurope.com/news/glaucoma-staging-systems-may-underestimate-severity/2479639/daily0.7https://crstodayeurope.com/news/genentech-acquires-jecure-therapeutics/2479641/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-appoints-ron-honig-esq-as-svp-general-counsel-company-secretary/2479642/daily0.7https://crstodayeurope.com/news/seco-2019-puts-spotlight-on-vision-industry-trends/2479643/daily0.7https://crstodayeurope.com/news/orasis-announces-appointments-of-richard-l-lindstrom-eric-d-donnenfeld-and-john-berdahl-to-its-scientific-advisory-board/2479644/daily0.7https://crstodayeurope.com/news/interface-biologics-completes-pre-ind-meeting-with-fda-on-epidel-technology-for-treatment-of-posterior-inflammatory-eye-diseases/2479645/daily0.7https://crstodayeurope.com/news/acufocus-receives-ide-approval-from-the-fda-to-begin-clinical-study-of-the-ic-8-lens/2479646/daily0.7https://crstodayeurope.com/news/fda-approves-genentechs-actpen-the-actemra-autoinjector-for-giant-cell-arteritis-other-indications/2479647/daily0.7https://crstodayeurope.com/news/eyenovia-initiates-phase-3-microstat-program-for-pharmacologic-mydriasis-enrolls-first-patient-in-mist-1-study/2479648/daily0.7https://crstodayeurope.com/news/fda-revamping-clearance-procedures-for-medical-devices/2479649/daily0.7https://crstodayeurope.com/news/insulin-need-set-to-rise-20-by-2030-but-access-may-be-limited/2479650/daily0.7https://crstodayeurope.com/news/warby-parker-eyewear-now-available-to-people-enrolled-in-unitedhealthcare-medicare-advantage-plans/2479652/daily0.7https://crstodayeurope.com/news/takeda-gains-clearance-from-european-commission-for-shire-purchase/2479653/daily0.7https://crstodayeurope.com/news/permanent-j-code-issued-for-avedros-photrexa-drug-formulations/2479654/daily0.7https://crstodayeurope.com/news/oculis-appoints-new-members-of-senior-management-team/2479655/daily0.7https://crstodayeurope.com/news/verily-alcon-halt-work-on-glucose-sensing-smart-contact-lens/2479656/daily0.7https://crstodayeurope.com/news/georgia-eye-associates-affiliates-with-eyesouth-partners/2479657/daily0.7https://crstodayeurope.com/news/4d-molecular-therapeutics-announces-fda-orphan-drug-designation-granted-to-4d-110-for-the-treatment-of-choroideremia/2479659/daily0.7https://crstodayeurope.com/news/u-s-appeals-court-rules-against-allergan-over-validity-of-restasis-patents/2479660/daily0.7https://crstodayeurope.com/news/acuvue-oasys-with-transitions-light-intelligent-technology-named-among-times-best-inventions-of-2018/2479661/daily0.7https://crstodayeurope.com/news/recipients-of-the-2018-owl-awards-recognized-for-advancing-diversity-in-ophthalmology-leadership/2479662/daily0.7https://crstodayeurope.com/news/santen-enters-into-a-strategic-cooperation-with-off-italia-to-offer-new-treatment-options-to-its-customers-across-emea/2479663/daily0.7https://crstodayeurope.com/news/envision-research-institute-announces-search-for-post-doctoral-fellows-to-study-low-vision/2479664/daily0.7https://crstodayeurope.com/news/american-academy-of-optometry-names-barbara-caffery-od-phd-faao-as-president/2479665/daily0.7https://crstodayeurope.com/news/santen-expands-research-and-development-leadership-team/2479666/daily0.7https://crstodayeurope.com/news/eyepatch-with-dissolvable-needles-used-to-treat-eye-disease/2479667/daily0.7https://crstodayeurope.com/news/eyegate-pharma-announces-positive-results-in-punctate-epitheliopathy-study/2479668/daily0.7https://crstodayeurope.com/news/prevent-blindness-opens-nominations-for-2019-jenny-pomeroy-award-for-excellence-in-vision-and-public-health/2479669/daily0.7https://crstodayeurope.com/news/new-melanoma-treatments-do-not-supplant-surgery-as-first-line-therapy/2479670/daily0.7https://crstodayeurope.com/news/eyegate-pharma-announces-positive-results-in-second-prk-study/2479671/daily0.7https://crstodayeurope.com/news/eyenovia-announces-fda-acceptance-of-microstat-ind-application-for-mydriasis/2479672/daily0.7https://crstodayeurope.com/news/small-particle-air-pollution-may-raise-glaucoma-risk-in-some/2479675/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-announce-26-35-million-collaboration-for-prevention-and-treatment-of-myopia/2479677/daily0.7https://crstodayeurope.com/news/takeda-shire-shareholders-to-vote-on-merger-deal-next-month/2479678/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-announces-assignment-of-permanent-j-code-for-dexycu-by-the-center-for-medicare-and-medicaid-services-cms/2479679/daily0.7https://crstodayeurope.com/news/prospective-study-for-naturalvue-multifocal-demonstrates-decreased-refractive-error-change-in-fast-progressing-myopic-children/2479681/daily0.7https://crstodayeurope.com/news/new-in-vitro-study-demonstrates-galimedix-therapeutics-investigational-compound-mrz-99030-eye-drops-neutralizes-the-reproduction-of-misfolded-amyloid-beta/2479684/daily0.7https://crstodayeurope.com/news/coopervision-forum-gathers-global-experts-in-childhood-myopia-identifies-improved-opportunities-to-assess-and-manage-the-condition/2479685/daily0.7https://crstodayeurope.com/news/millennial-demographics-drive-refractive-surgery-opportunity-in-us/2479686/daily0.7https://crstodayeurope.com/news/research-exposes-disparity-between-ecps-personal-wearing-habits-and-prescribing-habits-for-healthiest-contact-lens-material/2479687/daily0.7https://crstodayeurope.com/news/ehr-medication-lists-inaccurate-incomplete-blood-tests-show/2479689/daily0.7https://crstodayeurope.com/news/bauschs-papa-says-transformation-on-track-as-debt-paydown-continues/2479690/daily0.7https://crstodayeurope.com/news/webinar-today-create-a-winning-search-strategy-for-lasik-practices/2479691/daily0.7https://crstodayeurope.com/news/vital-tears-announces-the-addition-of-mobile-phlebotomy-services/2479692/daily0.7https://crstodayeurope.com/news/study-meditation-an-effective-therapy-to-reduce-eye-pressure-in-primary-open-angle-glaucoma/2479694/daily0.7https://crstodayeurope.com/news/eye-health-america-completes-acquisition-of-tampa-bay-based-updegraff-laser-vision/2479695/daily0.7https://crstodayeurope.com/news/pressure-intensifies-to-lower-drug-prices/2479696/daily0.7https://crstodayeurope.com/news/new-data-from-johnson-johnson-vision-highlights-the-need-and-potential-standards-for-evidence-based-decision-making-in-myopia/2479698/daily0.7https://crstodayeurope.com/news/oct-screening-before-cataract-surgery-can-improve-outcomes/2479699/daily0.7https://crstodayeurope.com/news/prevent-blindness-elects-three-new-members-to-national-board-of-directors-2/2479700/daily0.7https://crstodayeurope.com/news/nora-and-concussion-legacy-foundation-offer-new-educational-resource-on-vision-problems-and-symptoms-following-a-concussion/2479702/daily0.7https://crstodayeurope.com/news/migraine-associated-photophobia-appears-to-improve-after-botulinum-toxin-a-injections/2479703/daily0.7https://crstodayeurope.com/news/unum-finds-significant-number-of-millennials-value-vision-insurance/2479704/daily0.7https://crstodayeurope.com/news/semathera-board-names-garth-cumberlidge-as-president-ceo/2479705/daily0.7https://crstodayeurope.com/news/medicare-plans-to-phase-in-changes-for-office-visit-payments/2479706/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-to-showcase-new-data-and-interactive-experiences-at-2018-aaopt/2479707/daily0.7https://crstodayeurope.com/news/surgeon-age-doesnt-affect-cataract-surgery-outcomes/2479708/daily0.7https://crstodayeurope.com/news/oxurion-supporting-prevent-blindness-sight-saving-programs-for-those-with-diabetes/2479709/daily0.7https://crstodayeurope.com/news/ophthalmologists-implant-first-visian-toric-icls-in-the-us/2479710/daily0.7https://crstodayeurope.com/news/horizon-pharma-announces-presentation-of-results-of-48-week-off-therapy-follow-up-to-the-phase-2-trial-of-teprotumumab-at-aao/2479711/daily0.7https://crstodayeurope.com/news/aura-biosciences-reports-positive-phase-1b-2-clinical-data-for-au-011/2479713/daily0.7https://crstodayeurope.com/news/the-retina-group-of-washington-will-merge-with-marylands-retina-associates/2479714/daily0.7https://crstodayeurope.com/news/mount-sinai-health-system-top-presentations-and-abstracts-from-aao/2479715/daily0.7https://crstodayeurope.com/news/aao-unapproved-therapies-cause-significantly-more-patient-injuries-than-reported-by-cell-therapy-clinics/2479716/daily0.7https://crstodayeurope.com/news/nicox-postpones-nasdaq-listing-due-to-market-volatility/2479717/daily0.7https://crstodayeurope.com/news/vantage-eyecare-expands-in-philadelphia-area-with-the-addition-of-three-eyecare-practices/2479718/daily0.7https://crstodayeurope.com/news/report-laser-vision-correction-procedure-volume-increases-for-third-straight-year/2479719/daily0.7https://crstodayeurope.com/news/aao-announces-4-million-gift-to-aid-construction-of-a-public-museum-dedicated-to-vision-and-eye-health/2479720/daily0.7https://crstodayeurope.com/news/study-diabetes-medication-may-protect-against-amd/2479722/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-presents-positive-yutuq-24-month-follow-up-data-at-aao/2479724/daily0.7https://crstodayeurope.com/news/evidence-mounts-that-an-eye-scan-may-detect-early-alzheimers-disease/2479725/daily0.7https://crstodayeurope.com/news/spectralis-high-magnification-module-receives-fda-clearance/2479726/daily0.7https://crstodayeurope.com/news/zeiss-introduces-new-advances-in-astigmatism-management-and-glaucoma-imaging-at-aao/2479729/daily0.7https://crstodayeurope.com/news/novaliq-announces-positive-topline-results-for-its-seecase-phase-2-trial-of-nov03-for-the-treatment-of-patients-with-dry-eye-disease/2479732/daily0.7https://crstodayeurope.com/news/oyster-point-announces-positive-results-from-two-phase-2b-clinical-trials-of-investigational-treatments-for-dry-eye-disease/2479733/daily0.7https://crstodayeurope.com/news/checkedup-announces-expanding-reach-in-vision-care-and-new-product-features-at-the-point-of-care/2479734/daily0.7https://crstodayeurope.com/news/first-patient-screened-in-mallinckrodt-phase-4-trial-of-h-p-acthar-gel-for-severe-noninfectious-intermediate-uveitis-posterior-uveitis-or-panuveitis/2479736/daily0.7https://crstodayeurope.com/news/international-innovators-in-medical-and-surgical-eye-health-to-convene-in-chicago-to-advance-patient-care/2479737/daily0.7https://crstodayeurope.com/news/ellex-launches-eye-prime-new-ultrasound-solution/2479738/daily0.7https://crstodayeurope.com/news/eyemd-to-debut-its-eyemd-electronic-medical-records-2-0-release/2479739/daily0.7https://crstodayeurope.com/news/reay-h-brown-md-joins-sight-sciences-as-chief-medical-officer/2479741/daily0.7https://crstodayeurope.com/news/optovue-highlights-worlds-first-octa-metrics-and-corneal-measurement-method-at-aao-2018/2479742/daily0.7https://crstodayeurope.com/news/clerio-vision-first-noninvasive-laser-vision-correction-procedures-performed/2479743/daily0.7https://crstodayeurope.com/news/santen-launches-verkazia-for-children-and-adolescents-with-severe-allergic-eye-condition/2479744/daily0.7https://crstodayeurope.com/news/topcon-introduces-topcon-harmony-and-triton-swept-source-oct-at-the-2018-aao/2479746/daily0.7https://crstodayeurope.com/news/foundation-fighting-blindness-launches-retinal-degeneration-fund/2479747/daily0.7https://crstodayeurope.com/news/alcon-to-showcase-latest-innovations-at-american-academy-of-ophthalmology-2018-annual-meeting/2479748/daily0.7https://crstodayeurope.com/news/fda-warns-against-using-raindrop-near-vision-inlay/2479749/daily0.7https://crstodayeurope.com/news/eyevance-pharmaceuticals-acquires-exclusive-rights-to-commercialize-flarex-in-the-united-states/2479751/daily0.7https://crstodayeurope.com/news/bausch-lomb-to-launch-first-in-class-surgical-support-applications-for-stellaris-elite-on-ibm-cloud/2479752/daily0.7https://crstodayeurope.com/news/non-contact-panretinal-photocoagulation-for-navilas-577s-introduced-at-aao-2018/2479753/daily0.7https://crstodayeurope.com/news/optos-and-amydis-establish-clinical-alliance-to-develop-early-diagnostic-test-for-alzheimers-disease/2479754/daily0.7https://crstodayeurope.com/news/new-corneagen-interactive-education-program-to-offer-free-online-training-for-all-surgeons/2479755/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-to-showcase-new-products-data-educational-opportunities-and-charitable-giving-at-2018-aao/2479756/daily0.7https://crstodayeurope.com/news/ziemer-usa-offers-schedule-of-expert-speakers-at-aao/2479757/daily0.7https://crstodayeurope.com/news/carl-zeiss-meditec-to-acquire-iantech-maker-of-the-miloop-device-for-cataract-surgery/2479758/daily0.7https://crstodayeurope.com/news/johnson-johnson-vision-launches-myacuvue-subscription-program/2479759/daily0.7https://crstodayeurope.com/news/alcon-to-develop-smart-suite-digital-health-platform-for-cataract-surgery/2479762/daily0.7https://crstodayeurope.com/news/aerie-pharmaceuticals-establishes-gmp-print-production-facility-in-an-expanded-global-headquarters/2479763/daily0.7https://crstodayeurope.com/news/melt-pharmaceuticals-initiates-clinical-development-program-for-its-patented-mk-melt-conscious-sedation-drug-candidate/2479764/daily0.7https://crstodayeurope.com/news/idx-and-topcon-sign-exclusive-ai-platform-agreement-for-the-u-s-market/2479766/daily0.7https://crstodayeurope.com/news/owl-to-host-signature-event-and-awards-ceremony-at-aao-2018/2479767/daily0.7https://crstodayeurope.com/news/allergan-to-present-new-data-on-investigational-medicines-at-aao/2479768/daily0.7https://crstodayeurope.com/news/oxurion-extends-partnership-with-retina-global-in-support-of-bolivian-diabetic-retinopathy-boldr-project/2479770/daily0.7https://crstodayeurope.com/news/orasis-announces-the-appointment-of-jeffry-weinhuff-as-chairman-of-the-board-of-directors/2479771/daily0.7https://crstodayeurope.com/news/santen-announces-initiation-of-phase-3-clinical-development-program-spectrum-in-the-united-states-evaluating-omidenepag-isopropyl-de-117-for-the-treatment-of-glaucoma-or-ocular-hypertension/2479772/daily0.7https://crstodayeurope.com/news/takeda-gets-japanese-approval-for-62-billion-shire-purchase/2479773/daily0.7https://crstodayeurope.com/news/hoya-surgical-optics-to-acquire-ophthalmic-medical-device-companies-mid-labs-fritz-ruck/2479775/daily0.7https://crstodayeurope.com/news/corneagen-partners-with-visiometrics-to-offer-hd-analyzer-tear-film-analyzer/2479776/daily0.7https://crstodayeurope.com/news/i-med-pharma-partners-with-quidel-to-introduce-i-lid-n-lash-i-relief-and-smtube-to-the-us-market/2479777/daily0.7https://crstodayeurope.com/news/nicox-provides-third-quarter-2018-business-update-and-financial-highlights/2479778/daily0.7https://crstodayeurope.com/news/oculus-announces-new-joystick-for-the-keratograph-5m-with-release-function/2479779/daily0.7https://crstodayeurope.com/news/us-proposes-rule-requiring-drugmakers-to-disclose-list-prices-of-drugs-in-dtc-advertising/2479780/daily0.7https://crstodayeurope.com/news/imprimisrx-to-feature-new-formulation-and-poster-presentation-on-mko-melt-at-aao-meeting-in-chicago/2479781/daily0.7https://crstodayeurope.com/news/kala-pharmaceuticals-submits-nda-to-fda-for-kpi-121-0-25-for-dry-eye-disease/2479782/daily0.7https://crstodayeurope.com/news/moorfields-dubai-hosts-world-association-of-eye-hospitals-board-meeting/2479783/daily0.7https://crstodayeurope.com/news/increasing-surgery-volume-will-fuel-single-use-ophthalmic-surgical-device-market/2479784/daily0.7https://crstodayeurope.com/news/aura-biosciences-to-present-phase-1b-2-clinical-data-for-au-011-at-aao/2479786/daily0.7https://crstodayeurope.com/news/eyepoint-pharmaceuticals-receives-fda-approval-of-yutiq-for-noninfectious-uveitis/2479787/daily0.7https://crstodayeurope.com/news/falls-in-elders-may-be-driving-up-secondary-diagnoses-of-eye-trauma/2479788/daily0.7https://crstodayeurope.com/news/flying-eye-hospital-celebrates-20-years-of-eye-care-in-ethiopia-this-world-sight-day/2479789/daily0.7https://crstodayeurope.com/news/pennsylvania-senate-approves-bill-that-would-expand-optometrists-scope-of-practice/2479790/daily0.7https://crstodayeurope.com/news/ziemer-usa-offers-femtosecond-laser-wet-labs-at-aao/2479791/daily0.7https://crstodayeurope.com/news/market-scope-announces-launch-of-new-website-and-entry-into-orthopedics/2479792/daily0.7https://crstodayeurope.com/news/novaliq-raises-new-capital-to-accelerate-the-commercialization-of-its-lead-products-for-dry-eye-disease/2479793/daily0.7https://crstodayeurope.com/news/igf1-targeting-teprotumumab-tackles-thyroid-eye-disease/2479794/daily0.7https://crstodayeurope.com/news/konan-medical-usa-acquires-objectivefield-objective-perimeter/2479795/daily0.7https://crstodayeurope.com/news/coopervisions-best-practices-reveal-inaugural-eyedea-lab-findings-at-vision-expo-west/2479796/daily0.7https://crstodayeurope.com/news/vsp-global-announces-executive-team-appointments/2479797/daily0.7https://crstodayeurope.com/news/staar-surgical-announces-agreement-with-dr-tobias-neuhann-in-germany-to-create-collaboration-with-single-site-ophthalmology-clinics/2479798/daily0.7https://crstodayeurope.com/news/righteye-eye-tracking-system-receives-fda-510k-clearance/2479799/daily0.7https://crstodayeurope.com/news/sensimed-announces-approval-of-the-sensimed-triggerfish-in-japan/2479800/daily0.7https://crstodayeurope.com/news/alcon-expands-surgical-offerings-with-portfolio-of-mydriatic-cycloplegic-diagnostic-and-anesthetic-products/2479801/daily0.7https://crstodayeurope.com/news/ema-accepts-drug-application-for-regulatory-approval-of-rhokiinsa-rhopressa/2479802/daily0.7